Skip to content

To study the effect of KiratatiktaChurna in the management of Prameha with special reference to BSL & HbA1C.

Single Arm Clinical Study To Evaluate Add On Effect Of Kiratatikta Churna In The Management Of Prameha With Special Reference To Blood Sugar Level And HbA1C - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080275
Enrollment
40
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Dr Kaustubh Kailas Shinde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diabetic Patient having their Fasting blood glucose level more than 80 mg/dl and less than 120 mg/dl. 2.Diabetic Patient having Post prandial blood glucose level more than 200 mg/dl and less than 350 mg/dl. 3.Diabetic Patient having HbA1C more than 6.5 % and less than 10.5 %. 4Patient who is taking regular Diabetic drugs

Exclusion criteria

Exclusion criteria: 1.Patients having age below 35 years and more than 60 years. 2.Acromegaly, Cushing s syndrome and Pancreatic disorder. 3.Pregnant and lactating women. 4.Patient with gestational diabetes. 5.Patient suffering from Hepatic dysfunction, Renal dysfunction or Liver cirrhosis. 6.Those who are under Insulin therapy [IDDM]. 7.Patient with Lactic acidosis, Sepsis. 8.Patients with acute complications like hyperglycemic coma, ketoacidosis and infections like gangrene.

Design outcomes

Primary

MeasureTime frame
To study the effect of KiratatiktaChurna in the management of Prameha with special reference to BSL & HbA1C.Timepoint: 30 Days

Secondary

MeasureTime frame
1.To study the Nidanapanchaka of Prameha according to Ayurveda Samhita. 2.To study Diabetes mellitus according to modern science. 3.To study KiratatiktaChurna in detail. 4.To study the BSL & HbA1C test. 5.To study the efficacy of KiratatiktaChurna in the management of Prameha with special reference to BSL & HbA1C. Timepoint: 90 Days

Countries

India

Contacts

Public ContactDr Abhay Mahavir Khot

LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Urun Islampur

drabhay1988khot@gmail.com9172710091

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026